Astrana Health
ASTH
139 hedge funds and large institutions have $854M invested in Astrana Health in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 50 reducing their positions, and 30 closing their positions.
466% more call options, than puts
Call options by funds: $9.36M | Put options by funds: $1.65M
4% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 50
0.73% more ownership
Funds ownership: 38.42% → 39.15% (+0.73%)
7% less funds holding
Funds holding: 149 → 139 (-10)
30% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 30
32% less capital invested
Capital invested by funds: $1.26B → $854M (-$403M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Ophir Asset Management
Sydney,
Australia
|
+$15.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$14.3M |
| 3 |
SW
SteelPeak Wealth
Woodland Hills,
California
|
+$6.19M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
+$4.95M |
| 5 |
Morgan Stanley
New York
|
+$3.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$19.3M |
| 2 |
Goldman Sachs
New York
|
-$6.43M |
| 3 |
Millennium Management
New York
|
-$2.81M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.55M |
| 5 |
Jane Street
New York
|
-$2.28M |
ASTH Hedge Fund Activity: Q1 2022 in Review
139 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q1 2022, worth a combined $854M — down 32% from $1.26B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of ASTH and 21 opened new positions — a net loss of 9 holders — while 50 trimmed existing stakes and 52 added.
The largest buyer was Ophir Asset Management, opening a new position worth an estimated $15.4M. The largest seller was Eagle Asset Management, exiting entirely with an estimated $19.3M sold.
- 139 institutional investors held Astrana Health (ASTH) as of Q1 2022, down from 149 in Q4 2021.
- Funds reported $854M of Astrana Health stock for Q1 2022, down 32% quarter-over-quarter.
- 21 funds opened new Astrana Health positions in Q1 2022 and 30 closed out, a net change of -9 holders.
- The largest Astrana Health buyer in Q1 2022 was Ophir Asset Management, an estimated $15.4M added.
- The largest Astrana Health seller in Q1 2022 was Eagle Asset Management, an estimated $19.3M sold.
Based on aggregated 13F filings for Q1 2022.